These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10874916)

  • 1. [Drug prescriptions outside the marketing product license and its responsibilities].
    Gromb S; Maurain C; Carbonnel S
    Presse Med; 2000 May 27-Jun 3; 29(19):1053-7. PubMed ID: 10874916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prescription of drugs without approval to be commercialized].
    Bégué D
    Ann Chir Plast Esthet; 2004 Feb; 49(1):49-60. PubMed ID: 15013536
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prescribing medication in 2013: legal aspects].
    Berland-Benhaïm C; Bartoli C; Karsenty G; Piercecchi-Marti MD
    Prog Urol; 2013 Nov; 23(15):1201-7. PubMed ID: 24183075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient access to pharmaceuticals: an international comparison.
    Cohen J; Faden L; Predaris S; Young B
    Eur J Health Econ; 2007 Sep; 8(3):253-66. PubMed ID: 17279403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribing outside the limits of marketing authorizations and reimbursement by the French universal health insurance system.
    Avouac B
    Joint Bone Spine; 2002 Dec; 69(6):534-7. PubMed ID: 12537259
    [No Abstract]   [Full Text] [Related]  

  • 6. [[Selected legal aspects related to medical practice].
    Szewczyk M
    Folia Med Cracov; 1998; 39(3-4):97-120. PubMed ID: 10816962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Status of drugs].
    Gindre I; Woronoff-Lemsi MC
    Soins; 1998 Nov; (630):57-8. PubMed ID: 10095734
    [No Abstract]   [Full Text] [Related]  

  • 8. New modalities of prescription of ATUns: Evolutions and revolution.
    Vignot S; Plaine G; Chapel E
    Rev Neurol (Paris); 2020 May; 176(4):290-292. PubMed ID: 31611006
    [No Abstract]   [Full Text] [Related]  

  • 9. Homoeopathy: not a matter for drug-regulatory authorities.
    Garattini S; Bertelé V
    Lancet; 2009 Nov; 374(9701):1578-80. PubMed ID: 19674776
    [No Abstract]   [Full Text] [Related]  

  • 10. Feedback and lessons from the prescription of rimonabant, a drug to be used under strict guidelines, in southeastern France, March 2007 through June 2008.
    Jardin M; Cortaredona S; Bocquier A; Nauleau S; Sciortino V; Bouvenot J; Sauze L; Bouvenot G; Verger P
    Rev Epidemiol Sante Publique; 2011 Apr; 59(2):115-22. PubMed ID: 21435807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic aspects of the new Spanish laws on pharmaceutical preparations.
    Antoñanzas F; Oliva J; Pinillos M; Juàrez C
    Eur J Health Econ; 2007 Sep; 8(3):297-300. PubMed ID: 17401592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The First Amendment and FDA restrictions on off-label uses: the call for a new approach.
    Leghorn J; Brophy E; Rother P
    Food Drug Law J; 2008; 63(2):391-406. PubMed ID: 18561466
    [No Abstract]   [Full Text] [Related]  

  • 13. A cohort study of therapeutic prescriptions after the end of phytotherapy drug reimbursement by French Social Security.
    Riou França L; Vidal C; Bourechak N; Jeunne PL; Deville GS; Massol J
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):760-8. PubMed ID: 23208799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of off-label marketing regulations in the post-Sorrell era.
    Iraggi J
    Seton Hall Law Rev; 2013; 43(3):1137-63. PubMed ID: 23802338
    [No Abstract]   [Full Text] [Related]  

  • 15. Activities outside practice of medicine may carry their own liabilities. Wright v. Jeckle.
    West JC
    J Healthc Risk Manag; 2001; 21(3):37-8. PubMed ID: 11507945
    [No Abstract]   [Full Text] [Related]  

  • 16. [Legal format and costs of prescriptions at the Central Hospital in Yaounde, Cameroon].
    Blatt A; Chambon R; Lemardeley P
    Med Trop (Mars); 1997; 57(1):37-40. PubMed ID: 9289607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medical responsibility].
    Lassale B
    Transfus Clin Biol; 2008 Nov; 15(5):303-6. PubMed ID: 18930689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restrictions on the reimbursement policy with regard to retail marketing of medicinal products in Poland.
    Zimmermann A
    Acta Pol Pharm; 2013; 70(2):339-43. PubMed ID: 23614291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications for Food and Drug Administration approval to market a new drug; postmarketing reports; reporting information about authorized generic drugs. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Jul; 74(143):37163-8. PubMed ID: 19655468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The legal aspects of "off label use" -- or: Doubtful private prescription].
    Internist (Berl); 2008 Mar; 49(3):322-7. PubMed ID: 18327518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.